Carmona Jose (CIK 1693612) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy ADCT (203,700 shares), Sell ADCT (25,880 shares), Buy ADCT (271,600 shares), Sell ADCT (53,236 shares), Buy ADCT (240,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | ADC Therapeutics SA (ADCT) | Chief Financial Officer | Buy | 203,700 | $0 |
| 2026-02-18 | ADC Therapeutics SA (ADCT) | Chief Financial Officer | Sell | 25,880 | $103,261 |
| 2026-02-18 | ADC Therapeutics SA (ADCT) | Chief Financial Officer | Buy | 271,600 | $1.1M |
| 2025-12-09 | ADC Therapeutics SA (ADCT) | Chief Financial Officer | Sell | 53,236 | $175,146 |
| 2025-02-14 | ADC Therapeutics SA (ADCT) | Chief Financial Officer | Buy | 240,000 | $386,400 |
Source: SEC Form 4 filings · as of 2026-07-02